Meso Emerging Active

Novartis mengakuisisi firma bioteknologi Excellergy

Narasi baru dengan cakupan terbatas — masih terbentuk.

Skor
0,2
Kecepatan
▲ 0,0
Artikel
3
Sumber
2

Linimasa Sentimen

Linimasa Peristiwa

Apr 02, 2026
Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study Neutral
Mar 31, 2026
Centessa Pharmaceuticals Stock Soars 45% Over Acquisition Deal With Eli Lilly And … Bullish
Mar 28, 2026
Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion Neutral

Lini Waktu

Pertama TerlihatMar 28, 2026
Terakhir DiperbaruiMar 28, 2026